ROYAL BANK OF CANADA - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 74 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,000
+114.3%
12,707
+53.0%
0.00%
Q2 2023$14,000
+75.0%
8,306
+246.8%
0.00%
Q1 2023$8,000
-11.1%
2,395
+42.2%
0.00%
Q4 2022$9,000
-55.0%
1,684
-70.4%
0.00%
Q3 2022$20,000
+185.7%
5,682
+114.1%
0.00%
Q2 2022$7,000
-46.2%
2,654
-10.5%
0.00%
Q1 2022$13,000
-68.3%
2,966
-50.3%
0.00%
Q4 2021$41,000
+105.0%
5,973
+127.1%
0.00%
Q3 2021$20,0000.0%2,630
+33.6%
0.00%
Q2 2021$20,000
-33.3%
1,969
-37.5%
0.00%
Q1 2021$30,000
+275.0%
3,148
+326.0%
0.00%
Q4 2020$8,0007390.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders